Carlyle Puts Up $4B For J&J's Blood-Testing Unit
Private equity powerhouse The Carlyle Group LP announced Thursday that it will acquire Johnson & Johnson's blood-testing diagnostics unit, Ortho-Clinical Diagnostics Inc., for $4.15 billion....To view the full article, register now.
Already a subscriber? Click here to view full article